Eden Research (LON:EDEN) Sets New 1-Year Low – Time to Sell?

Posted by Hanz Christensen on Mar 27th, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 2.75 ($0.04) and last traded at GBX 2.90 ($0.04), with a volume of 281615 shares trading hands. The stock had previously closed at GBX 2.93 ($0.04).

Eden Research Stock Down 0.9 %

The stock has a market capitalization of £15.47 million, a price-to-earnings ratio of -10.16 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock has a 50 day moving average price of GBX 3.46 and a 200 day moving average price of GBX 3.75.

Insider Activity at Eden Research

In related news, insider Alexander John Abrey purchased 167,947 shares of the firm’s stock in a transaction dated Tuesday, March 4th. The stock was bought at an average price of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,486.94). Also, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction dated Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,183.98). Insiders acquired a total of 964,487 shares of company stock worth $3,690,001 in the last quarter. 14.02% of the stock is owned by insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.